GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
86 hedge funds and large institutions have $61.6M invested in G1 Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 17 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 87 → 86 (-1)
Holders
86
Holding in Top 10
–
Calls
$4.23M
Puts
$1.76M
Top Buyers
| 1 | +$1.89M | |
| 2 | +$1.79M | |
| 3 | +$1.62M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.25M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.2M |
Top Sellers
| 1 | -$2.71M | |
| 2 | -$1.39M | |
| 3 | -$1.26M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.1M |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$712K |